CERO THERAPEUTICS HOLDINGS, INC. Quarterly Assets, Current in USD from Q3 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Cero Therapeutics Holdings, Inc. quarterly Assets, Current history and growth rate from Q3 2021 to Q3 2024.
Cero Therapeutics Holdings, Inc. Assets, Current for the quarter ending September 30, 2024 was $3.71M.

Assets, Current, Quarterly (USD)

Assets, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$3.71M			Sep 30, 2024	10-Q/A	2024-11-20
Q2 2024	$4.25M			Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$5.5M			Mar 31, 2024	10-Q	2024-05-17
Q4 2023	$1.97M	-$40.4M	-95.4%	Dec 31, 2023	10-Q/A	2024-11-20
Q4 2022	$42.4M	+$41M	+3013%	Dec 31, 2022	10-K	2023-03-24
Q3 2022	$785K	+$761K	+3172%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$846K			Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$1.1M			Mar 31, 2022	10-Q	2022-05-13
Q4 2021	$1.36M			Dec 31, 2021	10-K	2023-03-24
Q3 2021	$24K			Sep 30, 2021	10-Q	2021-11-19

* An asterisk sign (*) next to the value indicates that the value is likely invalid.